Literature DB >> 20410226

Cortisol production rate is similarly elevated in obese women with or without the polycystic ovary syndrome.

Ferdinand Roelfsema1, Petra Kok, Alberto M Pereira, Hanno Pijl.   

Abstract

CONTEXT: The pituitary-adrenal axis in obesity and polycystic ovary syndrome (PCOS) is marked by increased urinary excretion of cortisol and its metabolites. It is not as yet clear whether the increased cortisol production in PCOS is related to obesity per se. INTERVENTION AND METHODS: We investigated 15 obese PCOS women with a body mass index of 30-54 kg/m(2) and 15 healthy obese controls (body mass index 31-60 kg/m(2)) with a regular menstrual cycle. Patients and control women underwent 24-h blood sampling at 20-min intervals. Cortisol concentrations were measured with a sensitive assay. Data were analyzed with a new deconvolution program, approximate entropy, and cosinor regression. OUTCOME: Basal, pulsatile, and total cortisol production expressed per liter distribution volume, per square meter body surface, and as absolute amount per 24 h was similar in PCOS patients and matched healthy control women. In addition, the regularity of cortisol secretion and the diurnal properties were identical. Compared with 10 lean control women, mean cortisol production per liter distribution volume was similar in the three groups, but the total 24-h cortisol production was increased in obese control women and PCOS women.
CONCLUSION: This study demonstrates equally increased cortisol production in PCOS women and obese healthy control women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410226     DOI: 10.1210/jc.2009-2701

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  Harmful effects of functional hypercortisolism: a working hypothesis.

Authors:  Giacomo Tirabassi; Marco Boscaro; Giorgio Arnaldi
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

2.  Effect of Ramadan Fasting on Stress Neurohormones in Women with Polycystic Ovary Syndrome.

Authors:  Farideh Zangeneh; Reza Salman Yazdi; Mohammad Mehdi Naghizadeh; Nasrin Abedinia
Journal:  J Family Reprod Health       Date:  2015-06

Review 3.  Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies.

Authors:  Renae C Fernandez; Vivienne M Moore; Emer M Van Ryswyk; Tamara J Varcoe; Raymond J Rodgers; Wendy A March; Lisa J Moran; Jodie C Avery; R Doug McEvoy; Michael J Davies
Journal:  Nat Sci Sleep       Date:  2018-02-01

Review 4.  Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment.

Authors:  Jim Parker; Claire O'Brien; Jason Hawrelak; Felice L Gersh
Journal:  Int J Environ Res Public Health       Date:  2022-01-25       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.